A pay structure meant to drive corporate success may be doing the opposite. A new study finds that one of the most common forms of CEO compensation – value-based equity grants – can actually weaken executive motivation and stifle innovation by discouraging long-term investments.

Navigating drones in environments without reliable Global Positioning System (GPS) signals remains a significant challenge for modern aerospace technology.

JMIR Aging, a leading open access journal focused on digital health and aging, announced the launch of a new dedicated section on “Advance Care Planning for Older Adults.”

A new FAU survey reveals that more than two-thirds of Floridians are moderately or extremely concerned about hurricanes increasing in strength and frequency, and more than half are worried about the ability to afford and maintain homeowners insurance due to climate change. Nearly two-thirds of Floridians believe that state and federal governments should be doing more to address the impacts of climate change. Most also support expanding the use of renewable energy. About 88% of all Floridians believe climate change is happening.

Cancer is the leading cause of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Due to its vague initial symptoms, cancer is often difficult to detect in its early stages. Liquid biopsy, a revolutionary approach in oncology, provides a minimally invasive, real-time method for cancer detection, monitoring, and characterization by examining circulating tumor components in body fluids. This review presents current technologies and clinical applications of liquid biopsy, focusing particularly on its value for early cancer diagnosis. Liquid biopsy enables molecular profiling of cancer for precision oncology by isolating circulating extracellular nucleic acids (cell-free DNA), circulating tumor DNA, and circulating tumor cells from blood and other body fluids. Cell-free DNA, which circulates freely in the blood, may or may not be tumor-derived, while circulating tumor DNA is specifically of tumor origin. Additionally, circulating tumor cells can be isolated from blood; these cells, shed from tumors into the bloodstream, typically survive only 1–2.5 h before immune clearance, though a small fraction can persist and metastasize to distant sites. Exosomes, small membrane-bound vesicles secreted by tumor cells, also carry molecular information about the tumor and have become a valuable source of biomarkers in liquid biopsy. Advances in detection technologies for these analytes have expanded the utility of liquid biopsy, facilitating the identification of somatic mutations and actionable genomic alterations in tumors. Finally, this review discusses the opportunities and challenges facing liquid biopsy and offers insights into its future development.